These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 16838382)

  • 1. Towards irreversible HIV inactivation: stable gp120 binding by nucleophilic antibodies.
    Nishiyama Y; Karle S; Mitsuda Y; Taguchi H; Planque S; Salas M; Hanson C; Paul S
    J Mol Recognit; 2006; 19(5):423-31. PubMed ID: 16838382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards covalent vaccination: improved polyclonal HIV neutralizing antibody response induced by an electrophilic gp120 V3 peptide analog.
    Nishiyama Y; Mitsuda Y; Taguchi H; Planque S; Salas M; Hanson CV; Paul S
    J Biol Chem; 2007 Oct; 282(43):31250-6. PubMed ID: 17728243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to the superantigenic site of HIV-1 gp120: hydrolytic and binding activities of the light chain subunit.
    Nishiyama Y; Karle S; Planque S; Taguchi H; Paul S
    Mol Immunol; 2007 Apr; 44(10):2707-18. PubMed ID: 17222909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing antibodies decrease the envelope fluidity of HIV-1.
    Harada S; Monde K; Tanaka Y; Kimura T; Maeda Y; Yusa K
    Virology; 2008 Jan; 370(1):142-50. PubMed ID: 17900650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.
    Paul S; Planque S; Zhou YX; Taguchi H; Bhatia G; Karle S; Hanson C; Nishiyama Y
    J Biol Chem; 2003 May; 278(22):20429-35. PubMed ID: 12665517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Journal club. A structural biologist has great expectations for llamas' small antibodies.
    Hwang WC
    Nature; 2009 May; 459(7245):303. PubMed ID: 19458671
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12.
    Huskens D; Van Laethem K; Vermeire K; Balzarini J; Schols D
    Virology; 2007 Apr; 360(2):294-304. PubMed ID: 17123566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is human immunodeficiency virus RNA load composed of neutralized immune complexes?
    Dianzani F; Antonelli G; Riva E; Turriziani O; Antonelli L; Tyring S; Carrasco DA; Lee H; Nguyen D; Pan J; Poast J; Cloyd M; Baron S
    J Infect Dis; 2002 Apr; 185(8):1051-4. PubMed ID: 11930314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coadsorption of HIV-1 p24 and gp120 proteins to surfactant-free anionic PLA nanoparticles preserves antigenicity and immunogenicity.
    Lamalle-Bernard D; Munier S; Compagnon C; Charles MH; Kalyanaraman VS; Delair T; Verrier B; Ataman-Onal Y
    J Control Release; 2006 Sep; 115(1):57-67. PubMed ID: 16919350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic alcohol drinking on receptor-binding, internalization, and degradation of human immunodeficiency virus 1 envelope protein gp120 in hepatocytes.
    Singh AK; Jiang Y; Gupta S
    Alcohol; 2007 Dec; 41(8):591-606. PubMed ID: 17980997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the interaction between focal adhesion kinase and CD4.
    Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
    J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells.
    Massanella M; Puigdomènech I; Cabrera C; Fernandez-Figueras MT; Aucher A; Gaibelet G; Hudrisier D; García E; Bofill M; Clotet B; Blanco J
    AIDS; 2009 Jan; 23(2):183-8. PubMed ID: 19098487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers.
    Goepfert PA; Tomaras GD; Horton H; Montefiori D; Ferrari G; Deers M; Voss G; Koutsoukos M; Pedneault L; Vandepapeliere P; McElrath MJ; Spearman P; Fuchs JD; Koblin BA; Blattner WA; Frey S; Baden LR; Harro C; Evans T;
    Vaccine; 2007 Jan; 25(3):510-8. PubMed ID: 17049679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1kappa monoclonal antibody, in HIV-1 infected cells.
    Clayton R; Ohagen A; Goethals O; Smets A; Van Loock M; Michiels L; Kennedy-Johnston E; Cunningham M; Jiang H; Bola S; Gutshall L; Gunn G; Del Vecchio A; Sarisky R; Hallenberger S; Hertogs K
    J Virol Methods; 2007 Jan; 139(1):17-23. PubMed ID: 17034868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate.
    Shibata J; Yoshimura K; Honda A; Koito A; Murakami T; Matsushita S
    J Virol; 2007 Apr; 81(8):3757-68. PubMed ID: 17251298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity.
    Braibant M; Brunet S; Costagliola D; Rouzioux C; Agut H; Katinger H; Autran B; Barin F
    AIDS; 2006 Oct; 20(15):1923-30. PubMed ID: 16988513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.
    Blish CA; Nedellec R; Mandaliya K; Mosier DE; Overbaugh J
    AIDS; 2007 Mar; 21(6):693-702. PubMed ID: 17413690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage.
    Bowley DR; Labrijn AF; Zwick MB; Burton DR
    Protein Eng Des Sel; 2007 Feb; 20(2):81-90. PubMed ID: 17242026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody.
    Johansson S; Goldenberg DM; Griffiths GL; Wahren B; Hinkula J
    AIDS; 2006 Oct; 20(15):1911-5. PubMed ID: 16988511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of diagnostic efficiency of the recombinant protein modeling immunodominant epitope V3 of envelope gp120 for immunoenzyme detection for HIV-1 infection antibodies].
    Riabinina SA; Baranova EN; Sharipova IN; Susekina MI; Puzyrev VF; Obriadina AP; Burkov AN; Ulanova TI
    Mol Gen Mikrobiol Virusol; 2007; (3):33-6. PubMed ID: 17886471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.